Linnaeus Therapeutics closed a $4.48 million equity round and won up to $22 million from a federal health agency. The company is studying pathways that may influence aging and disease.

The round was led by a digital health care-focused venture capital firm based in Wisconsin. Deadline: Friday, August 14, 2026 C-Suite Stars & Executive of the Year - 2026 The Milwaukee Business ...